Tanja Barth-Jaeggi, PhD
Tanja Barth-Jaeggi is a trained epidemiologist and nutritionist working in the Diseases and Programmes Unit of the Swiss Center for International Health at the Swiss Tropical and Public Health Institute. Her expertise includes the design, implementation, supervision and analysis of epidemiological field research (randomized controlled trials and surveys) on nutritional deficiencies and infectious diseases in Sub-Saharan Africa and South Asia. Further she has solid experience in the epidemiology and control of leprosy. She has interacted with national and international research partners and local governments in various parts of the world such as Côte d'Ivoire, India, Kenya, Mali, Myanmar, Senegal, South Africa, Sri Lanka, and Tanzania. Activities at the Swiss Center for International Health focus on applied research, health system and disease programmes monitoring and performance assessment in low- and middle-income countries.
Selected ProjectsAll Projects
Barth-Jaeggi T, Mäser P. Leishmaniasis in Europe and Central Asia: epidemiology, impact of habitat and lifestyle changes, HIV coinfection. In: Steinmann P,Utzinger J, eds. Neglected tropical diseases - Europe and Central Asia, 83-100. Cham: Springer, 2021. DOI: 10.1007/978-3-030-84224-6_5
Richardus J.H, Tiwari A, Barth-Jaeggi T, Arif M.A, Banstola N.L, Baskota R, Blaney D, Blok D.J, Bonenberger M, Budiawan T, Cavaliero A, Gani Z, Greter H, Ignotti E, Kamara D.V, Kasang C, Manglani P.R, Mieras L, Njako B.F, Pakasi T, Pandey B.D, Saunderson P, Singh R, Smith W.C.S, Staheli R, Suriyarachchi N.D, Tin Maung A, Shwe T, van Berkel J, van Brakel W.H, Vander Plaetse B, Virmond M, Wijesinghe M.S.D, Aerts A, Steinmann P. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. Lancet Glob Health. 2021;9(1):e81-e90. DOI: 10.1016/S2214-109X(20)30396-X
Barth-Jaeggi T, Zandberg L, Bahruddinov M, Kiefer S, Rahmarulloev S, Wyss K. Nutritional status of Tajik children and women: transition towards a double burden of malnutrition. Matern Child Nutr. 2020;16(2):e12886. DOI: 10.1111/mcn.12886
Barth-Jaeggi T, Cavaliero A, Aerts A, Anand S, Arif M, Sarady Ay S, Maung Aye T, Banstola N.L, Baskota R, Blaney D, Bonenberger M, van Brakel W, Cross H, Das V.K, Budiawan T, Fernando N, Gani Z, Greter H, Ignotti E, Kamara D, Kasang C, Kömm B, Kumar A, Lay S, Mieras L, Mirza F, Mutayoba B, Njako B, Pakasi T, Richardus J.H, Saunderson P, Smith C.S, Stäheli R, Suriyarachchi N, Shwe T, Tiwari A, Supun M, Wijesinghe D, van Berkel J, Vander Plaetse B, Virmond M, Steinmann P. Leprosy post-exposure prophylaxis with single-dose rifampicin: toolkit for implementation. Lepr Rev. 2019;90:356-363
Baumgartner J, Barth-Jaeggi T. Iron interventions in children from low-income and middle-income populations: benefits and risks. Curr Opin Clin Nutr Metab Care. 2015;18(3):289-294. DOI: 10.1097/MCO.0000000000000168
Jaeggi T, Kortman G.A, Moretti D, Chassard C, Holding P, Dostal A, Boekhorst J, Timmerman H.M, Swinkels D.W, Tjalsma H, Njenga J, Mwangi A, Kvalsvig J, Lacroix C, Zimmermann M.B. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731-742. DOI: 10.1136/gutjnl-2014-307720
Barth-Jaeggi T, Moretti D, Kvalsvig J, Holding P.A, Njenga J, Mwangi A, Chhagan M.K, Lacroix C, Zimmermann M.B. In-home fortification with 2.5 mg iron as NaFeEDTA does not reduce anaemia but increases weight gain: a randomised controlled trial in Kenyan infants. Matern Child Nutr. 2014;Suppl. 4:151-162. DOI: 10.1111/mcn.12163.